Market Overview

Morning Market Losers

Related GTXI
GTx Announces Enrollment of First Patient in Phase 2 Clinical Trial of Enobosarm in Triple Negative Breast Cancer
US Stock Futures Rise Ahead Of Housing, Consumer Confidence Data
Related STEM
Chardan Initiates Asterias Biotherapeutics At Buy On Potential Cell Therapy Competitiveness
Maxim Still Calling For 900% Upside At StemCells After Latest Phase II Data

GTX (NASDAQ: GTXI) plummeted 15.96% to $1.58 after the company announced its plans to lower 60% of its workforce.

StemCells (NASDAQ: STEM) dropped 14.29% to $1.44 after the company received the FDA authorization of IND for spinal cord injury.

Star Bulk Carriers (NASDAQ: SBLK) dropped 12.12% to $8.98 after the company announced a public offering of common stock.

Team (NYSE: TISI) dropped 11.53% to $35.39 after the company lowered its annual earnings outlook.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets


Related Articles (GTXI + SBLK)

View Comments and Join the Discussion!